Galapagos NV
GLPG
#4552
Rank
C$2.86 B
Marketcap
C$43.50
Share price
-0.69%
Change (1 day)
16.02%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2025 (TTM): C-$0.67

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is C-$0.47. In 2024 the company made an earnings per share (EPS) of C$1.60 a decrease over its 2023 EPS that were of C$4.87.

EPS history for Galapagos NV from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$0.67-141.84%
2024C$1.60-67.16%
2023C$4.87-199.64%
2022C-$4.8999.03%
2021C-$2.45-68.98%
2020C-$7.91-298.06%
2019C$4.00-554.64%
2018C-$0.88-77.18%
2017C-$3.85-326.21%
2016C$1.70-134.19%
2015C-$4.98-371.34%
2014C$1.84-445.98%
2013C-$0.5332.88%
2012C-$0.40-82.07%
2011C-$2.23-817.9%
2010C$0.3112.73%
2009C$0.28-120.79%
2008C-$1.32-37.67%
2007C-$2.1239.64%
2006C-$1.5228.17%
2005C-$1.196.25%
2004C-$1.12

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$15.28-3,384.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$5.14-1,205.50%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$3.28-805.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$2.83-708.98%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
C$10.02-2,254.65%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$7.34-1,677.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
C$5.17-1,211.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
C-$0.84 79.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$1.70-465.66%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel